Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic melanoma.

被引：0
|
作者：
Rother, J. [1 ]
Bailey, J. [1 ]
Alvarado, G. [1 ]
Prieto, V. G. [1 ]
Lazar, A. J. [1 ]
Jones, D. [1 ]
Hwu, W. J. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8050
引用
收藏
页码：465S / 465S
页数：1
相关论文
共 50 条
  • [41] Discovery of a kinome signature predicting sensitivity and resistance to RAF-MAPK pathway inhibitors in melanoma
    Hilhorst, Riet
    Krayem, Mohammed
    Van den Berg, Adrienne
    Journe, Fabrice
    Hovestad-Bijl, Liesbeth
    Van den Hooven, Tim
    de Wijn, Rik
    Aftimos, Philippe
    Ghanem, Ghanem
    Ruijtenbeek, Rob
    CANCER RESEARCH, 2017, 77
  • [42] Sprouty2 regulates positioning of retinal progenitors through suppressing the Ras/Raf/MAPK pathway
    Sun, Jian
    Yoon, Jaeho
    Lee, Moonsup
    Hwang, Yoo-Seok
    Daar, Ira O.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] Black Rice Anthocyanins Suppress Metastasis of Breast Cancer Cells by Targeting RAS/RAF/MAPK Pathway
    Chen, Xiang-Yan
    Zhou, Jie
    Luo, Li-Ping
    Han, Bin
    Li, Fei
    Chen, Jing-Yao
    Zhu, Yan-Feng
    Chen, Wei
    Yu, Xiao-Ping
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [44] Targets of p56(lck) activity in immature thymoblasts: Stimulation of the Ras/Raf/MAPK pathway
    Lin, K
    Abraham, KM
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (02) : 291 - 306
  • [45] Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
    Edoardo Isnaldi
    Anna Garuti
    Gabriella Cirmena
    Stefano Scabini
    Edoardo Rimini
    Lorenzo Ferrando
    Michela Lia
    Roberto Murialdo
    Lucia Tixi
    Enrico Carminati
    Andrea Panaro
    Maurizio Gallo
    Federica Grillo
    Luca Mastracci
    Lazzaro Repetto
    Roberto Fiocca
    Emanuele Romairone
    Gabriele Zoppoli
    Alberto Ballestrero
    Journal of Translational Medicine, 17
  • [46] Pan-RAF- MEK molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway
    Hoeflich, Klaus P.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (12)
  • [47] NST-628 is a potent, best-in-class MAPK pathway molecular glue that inhibits RAS- and RAF-driven cancers
    Ryan, Meagan B.
    Schenk, Natasha
    Zingg, Marshall
    Koehler, Matthew
    Sealm, Brooke
    Quade, Bradley
    Ye, Chaoyang
    Dar, Arvin C.
    Han, Yongxin
    Hoeflich, Klaus P.
    Hale, Michael R.
    Hagel, Margit
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [48] Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
    Isnaldi, Edoardo
    Garuti, Anna
    Cirmena, Gabriella
    Scabini, Stefano
    Rimini, Edoardo
    Ferrando, Lorenzo
    Lia, Michela
    Murialdo, Roberto
    Tixi, Lucia
    Carminati, Enrico
    Panaro, Andrea
    Gallo, Maurizio
    Grillo, Federica
    Mastracci, Luca
    Repetto, Lazzaro
    Fiocca, Roberto
    Romairone, Emanuele
    Zoppoli, Gabriele
    Ballestrero, Alberto
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [49] Harmine suppresses hyper-activated Ras-MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
    Ji, Jiaojiao
    Yuan, Jiang
    Guo, Xiaoyu
    Ji, Ruifang
    Quan, Qinghua
    Ding, Mei
    Li, Xia
    Liu, Yonggang
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [50] Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
    MacDonald, TJ
    Brown, KM
    LaFleur, B
    Peterson, K
    Lawlor, C
    Chen, YD
    Packer, RJ
    Cogen, P
    Stephan, DA
    NATURE GENETICS, 2001, 29 (02) : 143 - 152
12345